1 Introduction CA72-4 is a high-molecular-weight, tumor-associated glycoprotein recognized by monoclonal antibodies B72.3 and CC49 against the TAG-72 epitope [1]. Serum CA72-4 rises markedly in several malignancies—especially gastric, gastrointestinal, and ovarian cancers. In gastric cancer, combining CA72-4 with CEA and CA19-9 enhances diagnostic sensitivity and aids postoperative monitoring [2, 3].
Zhiling Xu
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zhiling
Contact Zhiling, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack